![E 7820 63794 [Epub ahead of print] PubMed](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M8011_1620453722.gif?v=1629190802)
Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
[Epub ahead of print] PubMed PMID: 31663782
PubMed PMID: 28598564
AEE788 significantly lowers the expression levels of pEGFR and pVEGFR in HT29 cecal tumors and does not alter those of EGF
and thus topoisomerase II poisons will be less inhibitory in the K/VP
NBMPR is routinely used at concentrations of 0
E 7820 63794 [Epub ahead of print] PubMedE7820 is a 2 integrin inhibitor with potential antiangiogenic and antitumor activities. E7820 inhibits angiogenesis by suppressing integrin alpha 2, a cell adhesion molecule expressed on endothelial cells. Inhibition of integrin alpha 2 leads to an inhibition of cell cell interactions, endothelial cell matrix interactions, vascular endothelial cell proliferation and angiogenesis. Product information CAS Number: 289483 69 8 Molecular Weight: 336. 37
US$ 227.50
US$ 26.95
US$ 129.00
US$ 75.00
US$ 26.95
US$ 467.23
US$ 13.00
US$ 20.22
US$ 20.00
US$ 1249.50
US$ 369.13
US$ 783.00